PluriMes is part of a larger European effort

The European Commission’s HEALTH research programme recently granted a total of 42 million euros for stem cell research projects. PluriMes aims to build close links with all of the consortium funded under the EC programme and has already established closer, collaborative relations with three of the other projects. A common theme in these projects is the focus on understanding the mechanisms of self-renewal of  differentiation into mature functional cell types suitable for various cell-based therapeutic applications.

humEn logo 225px
ThymiStem_PMS_RubineRed 225px

HumEn, a project aimed at developing glucose-responsive, insulin-producing beta cells for future cell-replacement therapy in diabetes;

Neurostemcellrepair, a project aimed at taking human stem cells through the final steps toward clinical application in cell replacement therapy for neurological disorders such as Parkinson's Disease;

and ThymiStem, a program to develop stem cell approaches to boosting the immune system by repairing the thymus, a key organ for producing important immune cells. These four consortia will collaborate and coordinate training and outreach activities, sharing relevant basic knowledge and benefitting from existing synergies across the projects.

All of these stem cell research projects will collaborate with EuroStemCell, Europe’s stem cell hub, to provide reliable, independent information and road-tested educational resources on stem cells and their impact on society.

PluriMes also collaborates with other international stem cell consortia


The consortium Revive is a selected project of the ANR "Laboratoire d'Excellence" programme (2011 - 2019) with research activity on stem cells in regenerative biology and medicine. Their aim is to advance fundamental and applied research on stem cell biology.